Rui Luo

机构：Sun Yat-sen University, Anhui Medical University, University of California, Irvine, Fudan University, Society of Nuclear Medicine and Molecular Imaging, Affiliated Hospital of Southwest Medical University, First Affiliated Hospital of Sichuan Medical University, Sixth Affiliated Hospital of Sun Yat-sen University, Fuyang City People's Hospital, Mianyang Central Hospital, Deyang Stomatological Hospital, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Second Affiliated Hospital of Anhui Medical University, University of Hong Kong · ORCID：0000-0001-5280-0999

发表论文 95 篇 · 总被引 1054 次 · h-index 20

代表论文

• The Burden of Hepatitis B and C in Asia, 1990–2019: An Update Analysis From the Global Burden of Disease Study 2019 (2025 · Liver International · 被引 12)
• Preclinical evaluation of 89Zr/177Lu-labeled amatuximab for theranostic application in pancreatic ductal adenocarcinoma (2024 · International Journal of Pharmaceutics · 被引 9)
• Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review (2024 · BMC Oral Health · 被引 9)
• The burden of diseases attributable to high body mass index in Asia from 1990 - 2019: results from the global burden of disease study 2019 (2025 · Annals of Medicine · 被引 7)
• Preclinical evaluation of 89Zr/177Lu-labelled anti-B7-H3 monoclonal antibody for theranostics in B7-H3-positive liver cancer (2025 · European Journal of Pharmaceutical Sciences · 被引 3)
• scGPT: end-to-end protocol for fine-tuned retinal cell type annotation (2025 · Nature Protocols · 被引 3)